Synthesis of peptide radiopharmaceuticals for the therapy and diagnosis of tumor diseases
about
Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple IntegrinsRadiolabeled cyclic RGD peptides as radiotracers for tumor imagingPhysiological Effects of Ac4ManNAz and Optimization of Metabolic Labeling for Cell TrackingOne-pot two-step radiosynthesis of a new (18)F-labeled thiol reactive prosthetic group and its conjugate for insulinoma imagingFITC-conjugated cyclic RGD peptides as fluorescent probes for staining integrin αvβ3/αvβ5 in tumor tissues.Analysis of argentinated peptide complexes using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: Peptide = oxytocin, arg(8) -vasopressin, bradykinin, bombesin, somatostatin, neurotensin.Radiolabeling strategies for tumor-targeting proteinaceous drugs.Vectors for the delivery of radiopharmaceuticals in cancer therapeutics.Relevance of radiobiological concepts in radionuclide therapy of cancer.Preclinical Study of 68Ga-DOTATOC: Biodistribution Assessment in Syrian Rats and Evaluation of Absorbed Dose in Human OrgansA bis-MnII-DOTA complex for pulsed dipolar spectroscopy.Impact of dianionic and dicationic linkers on tumor uptake and biodistribution of [64 Cu]Cu/NOTA peptide-based gastrin-releasing peptide receptors antagonists.The impact of repeated cycles of radioligand therapy using [177Lu]Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancer.Evaluation of a Flexible NOTA-RGD Kit Solution Using Gallium-68 from Different 68Ge/68Ga-Generators: Pharmacokinetics and Biodistribution in Nonhuman Primates and Demonstration of Solitary Pulmonary Nodule Imaging in Humans.
P2860
Q26801806-B44ED9A6-EB47-417E-A6A7-37EC08634D90Q28072021-C18F66D8-E15D-463D-A307-71A875C41893Q33588180-61136D80-8212-483B-A631-13194867B3B2Q34473707-2F24C6D5-97D7-4E8D-9161-5D952380BAB2Q34556242-BC635AA6-78C7-4522-8B00-BB1609780517Q36016163-828B54BD-47BD-4155-AF1F-09D5ED6962F2Q38189541-BFD7F2AD-309C-4C6D-A426-A6A184E860FCQ38261959-9C50E38F-9152-4A12-A838-72B895FDDA18Q38751028-EC58D9C7-0496-4B22-ACFC-8B30E0701119Q39140677-A8EE5AB1-4FDB-4EF3-B719-FE45208E6AAFQ39887231-0648E574-D19F-43C7-9459-EAFEBBE8FFB9Q48303231-AE3D0BF5-BBFE-4ECA-896F-C1E3B0B8B997Q50777449-FE71DD2A-F525-4712-8144-3514D29878B2Q51771438-7751E30A-3D85-4EC5-86AE-9EF1AFFF8D64
P2860
Synthesis of peptide radiopharmaceuticals for the therapy and diagnosis of tumor diseases
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Synthesis of peptide radiopharmaceuticals for the therapy and diagnosis of tumor diseases
@ast
Synthesis of peptide radiopharmaceuticals for the therapy and diagnosis of tumor diseases
@en
Synthesis of peptide radiopharmaceuticals for the therapy and diagnosis of tumor diseases
@nl
type
label
Synthesis of peptide radiopharmaceuticals for the therapy and diagnosis of tumor diseases
@ast
Synthesis of peptide radiopharmaceuticals for the therapy and diagnosis of tumor diseases
@en
Synthesis of peptide radiopharmaceuticals for the therapy and diagnosis of tumor diseases
@nl
prefLabel
Synthesis of peptide radiopharmaceuticals for the therapy and diagnosis of tumor diseases
@ast
Synthesis of peptide radiopharmaceuticals for the therapy and diagnosis of tumor diseases
@en
Synthesis of peptide radiopharmaceuticals for the therapy and diagnosis of tumor diseases
@nl
P2860
P3181
P1433
P1476
Synthesis of peptide radiopharmaceuticals for the therapy and diagnosis of tumor diseases
@en
P2093
Mazen Jamous
Uwe Haberkorn
P2860
P304
P3181
P356
10.3390/MOLECULES18033379
P407
P50
P577
2013-03-14T00:00:00Z